Search Within

CTCR Scholars

Formats
  1. Meeting Abstract (873)
  2. Journal Article (564)
  3. Review (72)
  4. Research Letter (38)
  5. Editorial (29)
  6. Correspondence (24)
  7. Miscellaneous (17)
  8. Book Section (11)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. Department of Medicine (1415)
  2. Hematologic Malignancies, Division of (1082)
  3. MSK Grad Students (1018)
  4. Center for Hematologic Malignancies (985)
  5. Master of Science in Clinical and Translational Cancer Research (983)
  6. Survivorship Research (917)

More Groups

People
  1. Sergio Giralt (553)
  2. Miguel-Angel Perales (411)
  3. Michael Scordo (385)
  4. Gunjan Shah (341)
  5. Sean Devlin (333)
  6. Parastoo Dahi (305)

More People

Years
  1. 2025 (98)
  2. 2024 (251)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (318)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (144)
  4. Annals of Surgical Oncology (83)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (56)

More Publications

Publishers
  1. Elsevier Inc. (390)
  2. American Society of Hematology (372)
  3. American Society of Clinical Oncology (158)
  4. Nature Publishing Group (134)
  5. Springer (102)
  6. American Association for Cancer Research (65)

More Publishers

Results (1639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PLX-R18 (avoplacel), a placental expanded mesenchymal-like stromal cell therapy shows favorable safety and appears to improve incomplete hematopoietic recovery after hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Lazarus, H. M.; McGuirk, J. P.; Zuckerman, T.; Metheny, L.; Pineiro, L.; Litzow, M. R.; Rowley, S. D.; Avni, B.; Tamari, R.; Sheleg, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation
    Meeting Abstract

    Ponce, D. M.; Peled, J. U.; Tejura, B.; Ford, C.; van den Brink, M. R. M.; Lombardo, M. J.; Kosuri, S.; Khera, N.; Defilipp, Z.; von Moltke, L.
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 3 double-blind, randomized, placebo controlled study to evaluate the efficacy and safety of AB-205 plus standard of care (SOC) versus placebo plus standard of care in adults with lymphoma undergoing high-dose therapy and autologous hematopoietic cell transplantation (E-CELERATE) (NCT05181540) - Trials in progress
    Meeting Abstract

    Scordo, M.; Shouse, G.; Mountjoy, L.; Gauthier, J.; Dholaria, B.; Rowley, S. D.; Pantin, J. M.; Defilipp, Z.; Mead, M.; Finnegan, P.
    Blood (2022)

    Fulltext@MSK | Save
  • Evaluating stem cells to predict post-transplant relapse in the myelodysplastic syndromes
    Meeting Abstract

    Kroger, B.; Huang, Y.; Patel, P.; Afrough, A.; Kaur, G.; Anderson, L. D. Jr; Awan, F. T.; Ramakrishnan, P.; Verma, K.; Vittrup, R.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Trends in collection and utilization of autologous hematopoietic stem cells (APBHC) intended for transplant in patients with multiple myeloma
    Meeting Abstract

    Samuel, N.; Laufer, L.; Tanaguchi, R.; Rosiene, J.; Palesi, C.; Elkind, R.; Mantzaris, I.; Shastri, A.; Kornblum, N.; Sica, R. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world single center experience
    Meeting Abstract

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; Maclachlan, K. H.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C.; Akhlaghi, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Radiotherapy for secondary CNS lymphoma: Patterns of utilization and clinical outcomes
    Meeting Abstract

    Cederquist, G. Y.; Tringale, K. R.; Hajj, C.; Hubbeling, H.; Fregonese, B.; Lee, J.; Scordo, M.; Grommes, C.; Yahalom, J.; Imber, B. S.
    Blood (2022)

    Fulltext@MSK | Save
  • Validation of a cell-free DNA NGS assay for hematological malignancies
    Meeting Abstract

    Gedvilaite, E.; DiNapoli, S.; Spence, C.; Diosdado, M. S.; Razumova, A.; Bowman, A. S.; Tsui, D. W. Y.; Salles, G.; Batlevi, C. L.; von Keudell, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • OGDH Is a genetic vulnerability and therapeutic target in acute myeloid leukemia
    Meeting Abstract

    Millman, S. E.; Chaves-Perez, A.; Morris, J. P. 4th; Chen, C. C.; Ho, Y. J.; Raman, S. J.; Yashinskie, J. J.; Mezzadra, R.; Narendra, V.; Tian, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A randomized placebo controlled study of a plant-based dietary versus supplement versus placebo intervention in patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) - the Nutrition Prevention (NUTRIVENTION-3) study
    Meeting Abstract

    Shah, U. A.; Castro, F.; Anuraj, A.; Schach, E.; Derkach, A.; Joseph, N. S.; Adintori, P. A.; Guttentag, L.; Blaslov, J.; Cross, J. R.; more...
    Blood (2022)

    Fulltext@MSK | Save